Cupid Ltd, a leading consumer wellness and personal care company, has reported that its net profit in the September quarter more than doubled to ₹56 core against ₹24 crore logged in the same period last year, largely due to strong demand across product portfolio.
Income increased more than doubled to ₹209 crore (₹90 crore). Profit before tax was up at ₹73 crore (₹32 crore).
The domestic business contributed ₹225 crore, accounting for 67 per cent of H1 FY27 sales compared with 41 per cent in FY26.
FY26, led by the Consumer Healthcare and FMCG business at ₹167 crore (49 per cent of sales), reflecting the growing scale and contribution of the company’s consumer portfolio, said Cupid in its presentation.
The international business contributed ₹113 crore, represented 33 per cent of H1 FY27 sales, supported by institutional demand, it added.
Cupid was allotted 1.01 crore convertible warrants of Baazar Style Retail (Style Baazar), reflecting a total investment commitment of ₹332 crore.
In May, Cupid converted 15 lakh warrants into equity shares at ₹328 per share, valued at ₹49 crore.
Subsequently, the company converted another 30 lakh warrants in September and October, taking total conversions to 45 lakh warrants, with an aggregate conversion value of ₹148 crore.
The company has deployed ₹193 crore, including upfront consideration. The remaining 56 lakh warrants are pending conversion, requiring an additional investment of about ₹138 crore upon conversion.
Aditya Kumar Halwasiya, Chairman & Managing Director, Cupid said the financial performance reflects the growing scale of the business in India and abroad.
Price revisions across export portfolio have also supported realisations, while the company remains focused on strengthening global partnerships and market presence, he said.
The exclusive partnership with V2 Retail provides dedicated retail space over 425 stores, with an expected revenue contribution of about ₹400 crore over the next 12 months, he added.
The company is evaluating a medical-devices manufacturing project in West Bengal, which would further broaden healthcare manufacturing base, he said.
Published on November 12, 2026
